CompletedNCT05200871

Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy)

Studying Nephrotic syndrome without extrarenal manifestations

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Travere Therapeutics, Inc.
Principal Investigator
Leah Conley, MBA
Travere Therapeutics
Enrollment
487 enrolled
Eligibility
18 years · All sexes
Timeline
20222023

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05200871 on ClinicalTrials.gov

Other trials for Nephrotic syndrome without extrarenal manifestations

Additional recruiting or active studies for the same condition.

See all trials for Nephrotic syndrome without extrarenal manifestations

← Back to all trials